Clinical trials help heart failure patients: study
Links shared publicly online about this topic.
- 1,557total visits
Clinical trials help heart failure patients: study
View full resource at healthcentral.com
Tags: Heart, Heart Disease, Heart Failure, Clinical Trial
Most Recently Shared on December 3, 2009 at 4:51 pm By:
healthcentral: Clinical trials help heart failure patients: study http://bit.ly/4WmQLr Full http://bit.ly/6VQvNU
Houston study shows stem-cell's potential for heart treatment - Houston Chronicle
chron.com — “Houston researchers are reporting that adult stem cells have a modest benefit in younger patients with heart failure, the first large-scale evidence that the controversial yet promising new therapy can be developed to help millions of people with the disease. In a study presented at a cardiology conference Saturday, Texas Heart Institute doctors presented results of a clinical trial showing that cells derived from patients' own bone marrow produce a small but significant increase in the heart's ” View full resource at chron.com
Most Recently Shared on March 26, 2012 at 5:51 pm By:
UTHealth Medical School and Healthcare System
Houston study shows stem-cell's potential for heart treatment - Houston Chronicle http://t.co/RWMPPDBN
Houston study shows stem-cell's potential for heart treatment - Houston Chronicle
chron.com — “Houston researchers are reporting that adult stem cells have a modest benefit in younger patients with heart failure, the first large-scale evidence that the controversial yet promising new therapy can be developed to help millions of people with the disease. In a study presented at a cardiology conference Saturday, Texas Heart Institute doctors presented results of a clinical trial showing that cells derived from patients' own bone marrow produce a small but significant increase in the heart's ” View full resource at chron.com
Most Recently Shared on March 26, 2012 at 7:45 am By:
Tom Heston, MD Family Medicine Doctor, Physician, and Doctor
Houston study shows stem-cell's potential for heart treatment - Houston Chronicle http://t.co/iwHQP3n1 #medicine
Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure
news-medical.net — “Boston Scientific Corporation has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients.” View full resource at news-medical.net
Most Recently Shared on September 30, 2011 at 5:14 am By:
Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure: Boston Scientific Corp... http://t.co/kz1NyORx
Press Release - Monitoring Heart Failure From Home - Northwestern Memorial Hospital - Chicago
nmh.org — “User-friendly device engages patients while helping physicians personalize treatment” View full resource at nmh.org
Most Recently Shared on September 20, 2011 at 6:57 pm By:
Clinical trial examines remote monitoring of heart failure progression. Northwestern 1 of 2 Illinois sites enrolling http://t.co/yVRtPAh1
Patients With COPD Benefit From Azithromycin - QualityPoint Technologies
qualitypointtech.net — “A common antibiotic can help reduce the severe wheezing and other acute symptoms of chronic obstructive pulmonary disease, according to a large, multicenter clinical trial sponsored by the National Institutes of Health and conducted at the University of California, San Francisco (UCSF). The study appears in the August 25 New England Journal of Medicine. Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the United States, surpassing strokes in 2008 - heart dis” View full resource at qualitypointtech.net
Most Recently Shared on August 31, 2011 at 8:45 am By:
Patients With COPD Benefit From Azithromycin: A common antibiotic can help reduce the severe wheezing and other ac... http://t.co/6tfrBza
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell - QualityPoint Technologies
qualitypointtech.net — “An article published in the Lancet revealed results of two clinical trials of omecamtiv mecarbil, a drug that according to researchers could one-day benefit heart failure patients by assisting the heart to contract more easily. Omecamtiv mecarbil, developed in San Francisco, activates a protein that increases the contraction of the heart muscle. First clinical trials indicate that it could help patients with stable systolic heart failure. Heart failure is defined as the inability of the heart to” View full resource at qualitypointtech.net
Most Recently Shared on August 22, 2011 at 12:45 am By:
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell: An article published in the Lancet revealed... http://t.co/rgzVcBM
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell
medicalnewstoday.com — “An article published in the Lancet revealed results of two clinical trials of omecamtiv mecarbil, a drug that according to researchers could one-day benefit heart failure patients by assist” View full resource at medicalnewstoday.com
Most Recently Shared on August 21, 2011 at 7:05 am By:
MNT Cardiovascular Health News
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell http://mnt.to/3Z69 #cardiovascular
Outcomes vary in global heart failure trials by geographic region
medicalxpress.com — “A comparison of several international clinical trials of beta-blocker drugs has shown there are notable differences in how well the drugs prevent deaths in heart failure patients, based on where the patients were treated. In this study, U.S. patients apparently had a lower survival rate with beta-blocker ...” View full resource at medicalxpress.com
Most Recently Shared on August 15, 2011 at 8:00 pm By:
PhysOrg Health News Health News
Outcomes vary in global heart failure trials by geographic region http://t.co/sLYCob0
ASCEND-HF: No Harm or Benefit with Nesiritide - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “With the publication of the final results of the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial) in the New England Journal of Medicine, the once intense controversy over the use-- or misuse-- of the drug nesiritide in patients with acute decompensated heart failure has [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 7, 2011 at 3:56 pm By:
Drugs and Devices OW OW Health
ASCEND-HF: No Harm or Benefit with Nesiritide: With the publication of the final results of the ASCEND-... http://onforb.es/p9usJq #drug
Medical News: HFC: Benefit for Some HF Patients in Telemonitoring - in Meeting Coverage, HFC from MedPage Today
medpagetoday.com — “GOTHENBURG, Sweden -- Remote monitoring doesn't boost heart failure clinical outcomes for patients overall but may help in newly diagnosed or unstable cases, researchers found in two clinical trials.” View full resource at medpagetoday.com
Most Recently Shared on May 23, 2011 at 5:59 pm By:
Patricia Grace Eldercare Expert
HFC: Benefit for Some HF Patients in Telemonitoring (CME/CE): (MedPage Today) -- GOTHENBURG, Sweden -- Remote m... http://bit.ly/mcKoJy
Medical News: HFC: Benefit for Some HF Patients in Telemonitoring - in Meeting Coverage, HFC from MedPage Today
medpagetoday.com — “GOTHENBURG, Sweden -- Remote monitoring doesn't boost heart failure clinical outcomes for patients overall but may help in newly diagnosed or unstable cases, researchers found in two clinical trials.” View full resource at medpagetoday.com
Most Recently Shared on May 23, 2011 at 5:58 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday HFC: Benefit for Some HF Patients in Telemonitoring (CME/CE) http://bit.ly/kKvkeG #medical #Health
Nile Therapeutics Announces Dosing Of First Patient In Phase I Study Of Cenderitide
medicalnewstoday.com — “Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, announced dosing of the first patient in a Phase I clinical trial i” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2011 at 7:05 am By:
Nile Therapeutics Announces Dosing Of First Patient In Phase I Study Of Cenderitide http://mnt.to/3VmR #heart #heartdisease
MedWire News - Cardiology - HF clinical trials --'continue to discriminate against older patients--™
medwire-news.md — “MedWire News Older patients continue to be excluded from heart failure clinical trials, often without good justification, the PREDICT study has found. MedWire News” View full resource at medwire-news.md
Most Recently Shared on April 4, 2011 at 12:52 pm By:
HF clinical trials ‘continue to discriminate against older patients’ http://bit.ly/fUQA4r #heartfailure
BG Medicine and Boston Scientific Make A Deal For Galectin-3 Heart-Failure Test | IVD Technology
ivdtechnology.com — “BG Medicine Inc. signed a deal for its galectin-3 heart-failure test with Boston Scientific Corp., as reported by MassDevice. Boston Scientific is studying whether BG Medicine's test can identify patients in need of cardiac-resynchronization therapy using patient data from Boston Scientific's Madit-CRT clinical trial.” View full resource at ivdtechnology.com
Most Recently Shared on April 1, 2011 at 10:18 pm By:
IVD Technology Health Magazine
BG Medicine and Boston Scientific Make A Deal For Galectin-3 Heart-Failure Test http://tinyurl.com/3tv4wdc
Symposier - Wireless Monitor Reduces Heart Failure Hospitalizations
symposier.com — “Uploaded and shared in Youtube by: osumedicalcenter --" http://bit.ly/eSojuD With millions of people hospitalized each year due to heart failure, results from a pivotal clinical trial show that an implantable pulmonary artery pressure device in patients with moderate heart failure results in significant reductions in hospitalizations and re-admissions for those patients. The study, published Feb. 10 in the Lancet, represents the first major breakthrough in heart failure management in the past de” View full resource at symposier.com
Most Recently Shared on March 4, 2011 at 10:51 pm By:
Symposier Cardiology Cardiology and Health Business
Wireless Monitor Reduces Heart Failure Hospitalizations, first major breakthrough in HF management in the past decade. http://bit.ly/hnushE
Advertisement
